Medicare claims data drives more of your MIPS score and coverage future than most wound care clinicians realize, but it was never built to capture what actually happens to a diabetic foot ulcer over six months of treatment. It was built to process payment, not to describe healing. That distinction matters because CMS increasingly leans on claims data to calculate cost measures, flag utilization patterns, and inform coverage policy, all without seeing a single wound measurement or healing trajectory. This article explains what Medicare claims data actually shows, where it falls short for wound care specifically, and how registry reporting through a Qualified Clinical Data Registry (QCDR) closes the gap between billing codes and clinical reality.
What Does Medicare Claims Data Actually Capture in Wound Care?
Medicare claims data consists of the administrative record generated every time a practice bills for a service: CPT and HCPCS codes, ICD-10 diagnosis codes, place of service, dates of service, and the payment amount adjudicated. It is a billing record, not a clinical one. Nothing in a claim describes wound size, tissue type, exudate volume, or whether a wound closed, stalled, or recurred. The claim simply tells CMS that a service was rendered, coded, and paid.
From this administrative layer, CMS can derive a fair amount: how often a given CPT code is billed, the average cost per episode of care, geographic variation in utilization, and proxies for adverse outcomes such as amputation or hospital readmission, inferred from subsequent diagnosis and procedure codes rather than from direct clinical documentation. These derived measures feed CMS’s public use files and several of the resource-use and readmission measures used across MIPS and hospital quality programs. CMS publishes the methodology for these measures on CMS.gov, and it is worth checking those specifications directly, because the technical details of how a “readmission” or “excess cost” is calculated change from one performance year to the next.
For wound care, this creates an odd asymmetry. A practice’s most clinically meaningful data point, whether a wound actually healed, lives in the chart, the photo, and the measurement log, not in the claim. The claim only shows that debridement, application of a cellular and tissue-based product (CTP), or hyperbaric oxygen therapy occurred, coded and billed at a certain rate. CMS then uses that billing pattern as a stand-in for quality and cost performance, even though it was never designed to answer the clinical question wound care is actually trying to answer.
How Does CMS Use Claims Data to Judge Wound Care Quality?
Cost measures under MIPS are calculated entirely from administrative claims. Clinicians submit nothing for the cost category, which accounts for 30% of the 2026 MIPS final score. That means a wound center’s “cost” score reflects the volume and price of billed services attributed to a patient’s episode of care, not the underlying complexity that drove those services. A center treating a high proportion of Wagner grade 3 and 4 ulcers, patients with peripheral arterial disease, or dialysis-dependent patients with slow-healing venous ulcers will generate more claims, more advanced therapeutics, and more total spend than a center that refers those patients elsewhere.
Without adequate risk adjustment for wound severity and comorbidity burden, that higher-complexity center simply looks more expensive on paper. CMS’s claims-based cost measures do apply risk adjustment, drawn largely from Hierarchical Condition Category (HCC) diagnosis groupings, but HCCs were built for general medical risk stratification, not wound-specific severity. HCC groupings collapse much of the wound detail that does appear on a claim, and they capture nothing about wound size, perfusion, or healing trajectory. Notably, none of the 35 cost measures in use for the 2026 performance year is specific to chronic wound care. CMS is developing a Non-Pressure Ulcers episode-based cost measure, which is slated for national field testing in 2026, but it is not yet part of MIPS scoring. The result is that clinical complexity gets flattened into a cost figure that can penalize exactly the centers taking on the hardest cases.
There is also a timing problem. CMS calculates cost measures only after the performance year ends and the claims have been finalized, and clinicians typically see their results in final MIPS performance feedback the following summer. A practice that improves its debridement practices or adds a hyperbaric program this quarter will not see that change reflected in a claims-based measure until long after the performance year is over. Claims data is retrospective by design. It cannot function as a real-time signal of quality improvement, which is precisely what MIPS scoring is supposed to reward.
Why Claims Data Alone Misrepresents Wound Care Complexity
The core limitation is granularity. Claims codes describe what was billed, not what was found on exam or how the wound responded over time. A wound that healed completely after four applications of a CTP and a wound that progressed to amputation despite the same four applications can generate remarkably similar-looking billing sequences. The CPT codes for application are identical; only the outcome differs, and the outcome is exactly what claims data cannot see.
A common misconception among clinicians is that CMS “sees” their difficult caseload through diagnosis coding. ICD-10 does carry some wound severity detail: non-pressure chronic ulcer codes specify depth (from skin breakdown through bone involvement), and pressure ulcer codes specify stage. But a diabetic foot ulcer code says nothing about wound size, perfusion, infection status, or how long the wound has been open, and that depth detail is largely flattened once diagnoses are grouped into HCCs for risk adjustment. Comorbidity burden, renal disease, peripheral neuropathy, immunosuppression, gets partial credit in HCC-based adjustment, but the interaction of these conditions with wound severity is not something claims coding was ever built to express with clinical fidelity.
Because CMS’s cost and quality measure methodology is revised annually, the specific weighting given to comorbidities and the exact measures applied to wound care specialties can shift from one performance year to the next. Clinicians and administrators should verify the current specifications directly on CMS.gov’s Quality Payment Program resource library before assuming last year’s rules still apply for the 2026 performance year. Relying on outdated assumptions about how claims-based measures are calculated is one of the more avoidable sources of MIPS score surprises.
How Does a QCDR Registry Fill the Gaps Claims Data Leaves Behind?
A Qualified Clinical Data Registry exists specifically to capture the clinical detail that claims data cannot. Rather than inferring outcomes from downstream billing codes, a wound care QCDR collects structured wound care data directly from the chart, typically documented in a wound care EHR: wound etiology, measurements over time, healing trajectory, hyperbaric oxygen therapy response, and closure or non-closure outcomes tied to specific treatment pathways. This is the difference between knowing a service was billed and knowing what happened to the wound as a result.
That clinical granularity is what makes risk-adjusted, specialty-specific measures possible. Instead of judging a wound center against cost or readmission measures built for general medicine or borrowed from unrelated specialties, a QCDR can build measures around wound healing rates for diabetic foot ulcers, venous leg ulcers, and pressure ulcers not located on the lower extremity, stratified by the severity and comorbidity data the registry actually captures. A clinic treating a higher share of Wagner grade 4 wounds, dialysis patients, or PAD-complicated ulcers can have that complexity reflected in its measure calculation, rather than penalized as unexplained cost or poor outcomes.
This distinction matters beyond MIPS scoring. Registry-derived, real-world wound care data has informed payer and policy conversations in ways that claims data alone could not, because it demonstrates actual healing rates and treatment patterns across a large population of complex patients rather than aggregate billing trends. When coverage policy questions arise, whether around hyperbaric oxygen therapy, CTPs, or negative pressure wound therapy, having chronic wound outcomes data that ties specific interventions to specific healing results carries more weight than claims volume alone. Clinical wound data can even be linked to claims through tokenization, pairing the billing record with what actually happened to the wound. For clinicians, participating in a registry is also the practical mechanism for earning MIPS credit through measures actually built for wound care, rather than relying only on the general measures available to every specialty.
What This Means for Your MIPS Score and Payment Risk
The practical stakes are straightforward. If your MIPS final score leans on claims-derived cost measures that cannot account for wound severity, and on general quality measures that were never designed for wound care, your score can end up lower than your actual clinical performance justifies, even when your healing outcomes are strong. A center doing excellent work with a difficult caseload can look mediocre or expensive on paper simply because the measurement tool wasn’t built for wound care.
Administrators should not wait passively for the final MIPS feedback report to find out how their case mix is being scored. Claims-based cost measure results arrive only in final performance feedback, after the performance year ends and after the data submission window has closed, so the time to prepare is before then. Reviewing prior-year feedback and patient-level data, along with any CMS field test reports for cost measures under development, alongside internal case-mix statistics, how many complex ulcers, PAD patients, or hyperbaric candidates the practice actually treats, helps clarify whether a low cost score reflects genuine inefficiency or simply the absence of wound-specific risk adjustment.
Registry reporting through a QCDR is the mechanism available to strengthen the part of the score clinicians control. QCDR measures count toward the MIPS Quality category; they do not change the cost category, which CMS calculates from claims regardless of how a practice reports. But rather than relying solely on general quality measures, a practice can report CMS-approved wound care quality measures, including risk-adjusted healing and closure rates for diabetic foot ulcers, venous leg ulcers, and pressure ulcers, along with process measures such as compression, offloading, and arterial assessment, all drawn from the chart rather than inferred from billing codes. Tools like a quality score benchmarking dashboard and an encounter-level quality scorecard help clinicians track that performance during the year rather than after it. For a wound center, hyperbaric program, or multi-site group under constant reimbursement pressure, a strong, wound-specific quality score is one of the best available offsets to a cost score that cannot see wound severity.
Protecting Your Score Against an Incomplete Data Picture
Claims data will always be part of how Medicare judges wound care. It is the backbone of CMS’s payment and audit infrastructure, and it is not going away. But clinicians and administrators who pair that claims-based view with risk-adjusted registry data through a QCDR are in a far stronger position: to defend their outcomes when a cost measure looks unfavorable, to earn quality credit through measures built for wound care, and to demonstrate, with structured clinical evidence rather than inference, the true complexity of the patients they treat. The gap between what a claim shows and what actually happened to a wound is exactly where registry data does its work. Learn more about the US Wound Registry’s CMS-approved wound care quality measures.
Recent Comments